OCT 30, 2019 8:25 AM PDT

Developing Animal-Free Neurotoxin Testing

WRITTEN BY: Nouran Amin

The need to assess a group of deadly neurotoxins without turning to animal-testing may soon be a possibility. A new animal-free testing technique was recently developed for paralytic neurotoxins by researchers at the University of Queensland. The technique will replace old conventional methods that often required the euthanasia of test subjects.

A temple pit viper from Gombak Valley, Malaysia (Credit: Scientistchic via University of Queensland).

"The old method, while extremely efficient, is limited in that it's slow and requires the euthanisation of animals in order to obtain the necessary tissue," says Associate Professor Bryan Fry, of UQ's Venom Evolution Lab. "Our new method uses optical probes dipped into a solution containing the venoms and we measure the binding to these probes -- the critical factor -- by analysing changes in the light reflected back. It's going to reduce the numbers of animals used for research testing, but it also has significant biomedical implications."

Examining paralytic neurotoxins is not just for research into anti-venoms, but testing these neurotoxins is often need for treating a broad spectrum of diseases and conditions.

"The team can now -- without the use of animal subjects -- screen venoms for non-target activities that may be relevant for drug design and development, helping treat all types of ailments," Dr Fry said. "For example, we've showed that temple pit viper venom has an unusual cross-reactivity for the human alpha-5 receptor, which is a major target for conditions including colitis and smoking. Who knows what other potential treatments the world's venoms could lead to -- we're excited to find out."

The technique depends on the production of synthetic peptides that attach to nerve receptors and allow muscles to contract.

"Neurotoxins, found in the venom of many types of snakes, cause paralysis by attaching to nerve receptors in our muscles, preventing the normal chemical binding process that naturally occurs in our bodies when we want to move," Dr. Fry said. "This is what stops a mouse fleeing from a snake after it has been bitten.

Learn more on why snake venom is so deadly:

"Since venoms bind to the synthetic peptides more vigorously than they do to human nerves, we're also investigating a new treatment of snakebite, using these peptides as 'decoys'”, adds Dr. Fry. "The venom would bind to them instead of their original nervous system target in the human body. Many species of deadly snake lack an effective anti-venom, so these sorts of applications may help meet this critical need.”

Source: The University of Queensland

About the Author
  • Nouran earned her BS and MS in Biology at IUPUI and currently shares her love of science by teaching. She enjoys writing on various topics as well including science & medicine, global health, and conservation biology. She hopes through her writing she can make science more engaging and communicable to the general public.
You May Also Like
JAN 18, 2020
Drug Discovery & Development
JAN 18, 2020
Drug Combo Targets Osteoarthritis
Individuals suffering from osteoarthritis often face challenges of limited treatment options mainly pain relievers or joint replacement surgery. However, s...
FEB 12, 2020
Drug Discovery & Development
FEB 12, 2020
Does Traditional Chinese Medicine Work Against Coronavirus?
Over 45,000 cases of Wuhan Coronavirus have been reported globally, alongside over 1,100 deaths. Although over 4,700 people are said to have recovered from...
MAR 07, 2020
Drug Discovery & Development
MAR 07, 2020
Single Trip on Magic Mushrooms Boosts Mindfulness
According to new research, a single trip from magic mushrooms is enough for people to experience long-term increases in mindfulness and openness. Mindfulne...
MAR 20, 2020
Drug Discovery & Development
MAR 20, 2020
4 Potential Treatments for SARS-CoV-2 Currently Under Testing
Currently, no medicine nor vaccine has been approved as effective for the prevention of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Despi...
MAR 16, 2020
Drug Discovery & Development
MAR 16, 2020
Critical Interleukin Leads to Drug Discovery
The immune molecule interleukin-2 (IL-2) is a growth factor that stimulates the immune system to produce T-cells. Their powerful effects have encouraged re...
MAR 29, 2020
Cancer
MAR 29, 2020
Improving ependymoma diagnostics
Have you ever heard of ependymoma? This rare form of brain cancer most commonly occurs in young children when tumors form from ependymal cells in the brain...
Loading Comments...